Volume 8, Number 12, December 2002

Antimicrobial Resistance of Escherichia coli O26, O103, O111, O128, and O145 from Animals and Humans

Carl M. Schroeder,* Jianghong Meng,* Shaohua Zhao,† Chitrita DebRoy,‡ Jocelyn Torcolini,‡ Cuiwei Zhao,* Patrick F. McDermott,† David D. Wagner,† Robert D. Walker,† and David G. White†
*University of Maryland, College Park, Maryland, USA; †U.S. Food and Drug Administration, Laurel, Maryland, USA; and ‡The Pennsylvania State University, University Park, Pennsylvania, USA

Figure 1. Comparison of antimicrobial resistance frequencies for Escherichia coli isolates from different sources. Am, ampicillin; Cx, cefoxitin; C, chloramphenicol; Frx, ceftriaxone; Smx, sulfamethoxazole; Cf, cephalothin; Gm, gentamicin; NA, nalidixic acid; Cip, ciprofloxacin; Fur, ceftiofur; Te, tetracycline; T/S, trimethoprim-sulfamethoxazole; A/C, amoxicillin-clavulanic acid; Str, streptomycin.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed March 21, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention